申请人:Board of Regents, The University of Texas System
公开号:US20190016713A1
公开(公告)日:2019-01-17
The present disclosure relates to heterocyclic compounds and methods which may be useful as inhibitors of ATR kinase for the treatment or prevention of cancer.
本公开涉及
杂环化合物和方法,这些方法可能作为ATR激酶的
抑制剂,用于治疗或预防癌症。